FORTISMLR.BO · BSE

FORTIS MALAR HOSPITALS LIMITED

₹41.77

+0.29% (+₹0.12)

Prev. close

₹41.65

Volume

5,204

As of

24 Sept 2026

Price history

₹41.77-₹11.34 (-21.35%) · 3M
23 Jun 202624 Sept 2026
₹53.11₹41.3123 Jun16 Jul10 Aug01 Sept24 Sept
Daily closes · updates after each session

No analyst calls on this stock in the last 90 days yet.

Explore by date range →

Analyst opinions

No analyst calls on FORTIS MALAR HOSPITALS LIMITED in the last 90 days.

Fundamentals

About FORTIS MALAR HOSPITALS LIMITED

Fortis Malar Hospitals Limited provides health care services in India. It operates and manages Fortis Malar Hospital, a multi-specialty hospital in Chennai. The company was formerly known as Malar Hospital. Fortis Malar Hospitals Limited was incorporated in 1989 and is based in Mohali, India. Fortis Malar Hospitals Limited is a subsidiary of Fortis Hospitals Limited.

Details

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Mr. Bidesh Chandra Paul

Headquarters

Mohali

Key stats

Market cap

₹78.06 Cr

P/E ratio (TTM)

595.0

EPS (TTM)

₹0.07

Beta (1Y · daily vs NIFTY 50)

0.92

Beta (5Y · monthly vs NIFTY 50)

0.99

Shares float

51.96 L

EPS · quarter ended Jun 2026

₹0.08

Financial Performance

01 · Financials

-50 Cr0 Cr50 Cr100 Cr-100%-50%0%50%FY21FY22FY23FY24FY25FY26
RevenueNet incomeEBITDARevenue growth YoY

Revenue for Mar 2021–Mar 2022 is as filed with BSE (consolidated), and the first plotted growth figure is computed against Mar 2020 revenue as filed with BSE; the two sources' revenue definitions differ by 0.2% on Mar 2023. FY21 growth needs FY20 filings, which the data source doesn't provide.

02 · Earnings Per Share (EPS)

-2002040FY21FY22FY23FY24FY25FY26

03 · Dividend Profile

0102030400%25%50%75%23 Apr 2424 Jul 24
Dividend (₹/share)Annualised yield

Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: Yahoo (no NSE corporate-actions ledger for this listing).

04 · Operating Efficiency (Growth Rates)

Balance-sheet-based · pre-FY23 not filed in verifiable form

-100%-50%0%50%FY21FY22FY23FY24FY25
SalesFixed assetsTrade receivablesInventory

05 · Capital Structure & Asset Utilization

Pre-FY23 not filed in verifiable form

0 Cr50 Cr100 Cr150 Cr0.25×0.5×0.75×FY22FY23FY24FY25FY26
Total assetsTotal debtDebt / equityAsset turnover

Asset turnover needs a prior year of assets — omitted for the earliest available year.

06 · Asset Base Composition

Pre-FY23 not filed in verifiable form

0 Cr50 Cr100 Cr150 CrFY21FY22FY23FY24FY25FY26
Fixed assetsCurrent assetsOther assets

07 · Debt Level & Coverage

Pre-FY23 not filed in verifiable form

-100 Cr0 Cr100 Cr200 CrFY21FY22FY23FY24FY25FY26
DebtFree cash flowCash & equivalents

08 · Profit & Loss

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹69.24 Cr₹86.18 Cr₹85.81 Cr₹58.85 Cr₹0₹0
EBITDA₹1.91 Cr₹15.09 Cr₹11.21 Cr₹63.67 Cr₹57.83 L₹4.73 Cr
₹-7.87 Cr₹-8.27 Cr₹-15.48 Cr₹45.32 Cr₹39.20 L₹4.14 Cr
Diluted EPS₹-4.2₹-4.41₹-8.26₹24.18₹0.21₹2.21

Depreciation & amortisation, Pretax income, Tax provision, Interest expense have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

09 · Balance Sheet

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹138.00 Cr₹115.88 Cr₹36.83 Cr₹37.60 Cr
Total debt₹53.41 Cr₹46.40 Cr₹0
Stockholders' equity₹64.17 Cr₹109.47 Cr₹30.21 Cr₹34.35 Cr

Total assets, Current assets, Trade receivables, Cash & equivalents, Non-current assets, Fixed assets, Total debt, Stockholders' equity have filed figures for only some of the years shown — the missing years are left blank rather than estimated. Inventory shows ₹0 for 2024-03-31 — this deck's own annual-report reading has no Inventory figure for this filer in any year shown (2024-03-31, 2021-03-31, 2025-03-31, 2026-03-31 alike); the ₹0 shown here comes from this filer's own reported data feed rather than this deck's own extraction, and is positively consistent with a filer that holds no physical inventory (typical for lenders and other financial-services companies) rather than a display default. 2021-03-31, 2025-03-31, 2026-03-31 have no Inventory figure reaching this deck at all — not shown as zero, not shown as positive — left blank rather than assumed to match the other years.

Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.

10 · Cash Flow Statement

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹5.61 Cr₹-7.30 Cr₹1.54 Cr₹62.46 L
Investing cash flow₹49.97 L₹119.70 Cr₹-29.10 Cr₹45.90 L
₹-12.65 Cr₹-10.85 Cr₹-79.65 Cr₹0
Capital expenditure₹-1.40 Cr₹-1.88 Cr₹-2.30 Cr
End cash position₹5.86 Cr₹107.41 Cr₹20.24 L₹1.29 Cr

Operating cash flow, Depreciation & amortization, Change in working capital, Investing cash flow, Financing cash flow, Dividends paid, Capital expenditure, End cash position have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source has no quarterly cash-flow-statement coverage.

12 · Peer Comparison

Healthcare

Company
Sun Pharmaceutical Industries Limited₹4.47 L Cr₹1,849.937.05.3513.7%0.06+11.9%+13.7%
Divi's Laboratories Limited₹2.55 L Cr₹9,60287.215.2415.3%0.00+12.3%+60.5%
Torrent Pharmaceuticals Limited₹1.90 L Cr₹4,928.579.522.6025.8%1.79+21.5%+36.3%
Apollo Hospitals Enterprise Limited₹1.30 L Cr₹8,888.561.013.7520.5%0.90+15.7%+16.3%
Lenskart Solutions Limited₹1.19 L Cr₹676180.713.615.6%0.35+35.4%
Zydus Lifesciences Limited₹1.17 L Cr₹1,180.326.14.3118.6%0.46+18.4%+13.9%
Cipla Limited₹1.12 L Cr₹1,39933.23.2411.3%0.02+2.1%-9.0%
Laurus Labs Limited₹1.10 L Cr₹2,026.2100.920.8416.8%0.48+22.0%+122.7%
Max Healthcare Institute Limited₹1.03 L Cr₹1,04671.19.6013.4%0.32+19.0%-7.7%
Mankind Pharma Limited₹1.02 L Cr₹2,50049.06.2511.7%0.39+17.0%-1.2%
Dr. Reddy's Laboratories Limited₹1.01 L Cr₹1,200.430.52.6811.4%0.21+3.2%-7.5%
FORTIS MALAR HOSPITALS LIMITED₹78.06 Cr₹41.65595.02.2712.0%-35.0%

Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.

Documents

Annual reports

Show all 26

Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.

No stock news captured yet.